Seizure-related ED visits before and during COVID-19 pandemic examined in US observational report
Study looks at seizure-related emergency visits before and during COVID-19
An observational report examined seizure or epilepsy-related emergency department visits in the United States before and during the COVID-19…
A new report tracks emergency visits for seizures and epilepsy in the US before and during the COVID-19 pandemic, but the study did not shar…
FDA Approves Lamotrigine for Adjunctive Therapy in Epilepsy and Maintenance in Bipolar I Disorder
FDA approves lamotrigine, a medicine for epilepsy and bipolar disorder.
Lamotrigine is approved for adjunctive therapy of partial-onset seizures, PGTC seizures, and seizures of Lennox-Gastaut syndrome in patients…
The FDA officially approves lamotrigine for epilepsy and bipolar disorder, confirming a long-used treatment option for adults and children a…